Beauty Health (SKIN) Projected to Release Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is expected to be issuing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $74.45 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The business had revenue of $64.91 million during the quarter, compared to analysts’ expectations of $66.28 million. On average, analysts expect Beauty Health to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Beauty Health Price Performance

SKIN opened at $0.64 on Thursday. The company has a market capitalization of $83.40 million, a price-to-earnings ratio of -3.79 and a beta of 1.08. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37. Beauty Health has a 12-month low of $0.55 and a 12-month high of $2.69. The business’s fifty day simple moving average is $0.73 and its 200-day simple moving average is $0.95.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in SKIN. Invesco Ltd. boosted its position in Beauty Health by 65.4% during the fourth quarter. Invesco Ltd. now owns 69,422 shares of the company’s stock valued at $96,000 after purchasing an additional 27,453 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in Beauty Health by 33.5% in the second quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock valued at $79,000 after purchasing an additional 10,410 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in Beauty Health by 256.4% in the third quarter. BNP Paribas Financial Markets now owns 38,361 shares of the company’s stock worth $76,000 after purchasing an additional 27,597 shares in the last quarter. Cerity Partners LLC bought a new position in Beauty Health in the fourth quarter worth about $64,000. Finally, Franklin Resources Inc. lifted its position in shares of Beauty Health by 157.1% during the fourth quarter. Franklin Resources Inc. now owns 39,654 shares of the company’s stock valued at $55,000 after buying an additional 24,231 shares during the last quarter. 93.26% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on SKIN. Weiss Ratings lowered shares of Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 23rd. Roth Capital restated a “buy” rating and issued a $2.00 price target (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Zacks Research cut shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Finally, Canaccord Genuity Group lowered their price target on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $2.02.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.